Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

362 requests
Make a request to this authority
Deaths and adverse events from fires caused by emollient skin creams
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Awaiting response.

Our Ref: FOI 20/420 Dear Georgia Richards, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received o...
Safety evidence for vaccine ingredients
Response by Medicines and Healthcare products Regulatory Agency to Athanasios Kandias on .

Awaiting classification.

Our Ref: FOI 20/421 Dear Athanasios Kandias, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received...
Fake Medicines
Response by Medicines and Healthcare products Regulatory Agency to Connor Griffith on .

Awaiting response.

Our Ref: FOI 20/416 Dear Connor Griffith, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on...
Documents held showing SARS-COV2 has been isolated and Causes COVID-19
Response by Medicines and Healthcare products Regulatory Agency to Athanasios Kandias on .

Awaiting response.

Our Ref: FOI 20/404 Dear Athanasios Kandias, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received...
Flu Vaccine-Associated suspected adverse reactions years 2014-2020
Response by Medicines and Healthcare products Regulatory Agency to Ivana Culham on .

Awaiting classification.

Dear Ivana Please find a response to your request attached. Kind regards, VRMM FOI Team Vigilance and Risk Management of Medicines Division Medicine...
UK clinical trials of investigative medicinal products
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Successful.

Reference CSC 15516     Dear Mr Bruckner,   Thank you for your email dated 16 September 2020 regarding Freedom of Information request - UK c...
UK clinical trials of medical devices
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Partially successful.

FOI 20/323   Dear Till Bruckner,   Thank you for your information request, dated 16^th September 2020, where you asked for:   1. Please provide...
Request for Copies of Instructions in UK SARS-COV2 Testing Kits
Response by Medicines and Healthcare products Regulatory Agency to Andrew Johnson on .

Refused.

Our ref: FOI 20/341   Dear Andrew Johnson,   Thank you for your email of 25 august 2020, in which you requested the following information unde...
Transportation and Temperature Records
Response by Medicines and Healthcare products Regulatory Agency to Jenit Singh on .

Awaiting classification.

Dear Jenit, Please see below. Kind regards, GDP Inspectorate MHRA officers endeavour to ensure that advice and comments offered reflect MHRA operat...
GDP Flexibilities
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

Dear Mr John Watts,   Thank you for your email.   Please find below answer to the questions you have raised below.   Transportation   T...
HPV Vaccine - Yellow Card Report Years 2000 - 2020
Response by Medicines and Healthcare products Regulatory Agency to Ivana Culham on .

Delayed.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team sh...
Number of new market authorisations for antidepressants and antitumour medicines in specific indications since 2000
Response by Medicines and Healthcare products Regulatory Agency to David King on .

Awaiting classification.

Our ref: FOI 20/332 Dear Mr King, Thank you for your email of 19 August 2020, in which you requested the following information under the Freedom of I...
Number of applicants for posts
Response by Medicines and Healthcare products Regulatory Agency to Peter C. Bell on .

Successful.

Our ref: FOI 20/313 Dear Mr Bell, Thank you for your email of 5 August 2020, in which you requested the following information under the Freedom of In...
MHRA updates of clinical trial statuses on EudraCT - progress
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Successful.

FOI 20/273     Dear Dr Bruckner,   Thank you for your email of 5th July 2020, in which you requested the following information under the Freedom...
Gemscript drug code to SNOMED/ DM+D code lookup
Response by Medicines and Healthcare products Regulatory Agency to A Gibney on .

Successful.

FOI 20/307 Dear A. Gibney, Thank you for your information request, dated 27th July 2020, where you asked: Can you provide a lookup table for all th...
Request for clinical overviews and approval information for Selenase® solution for injection in UK
Response by Medicines and Healthcare products Regulatory Agency to SK on .

Awaiting classification.

Our ref: FOI 20/305     Dear SKK,   Thank you for your email of 28 July 2020, where you requested the following information under the Freedom of...
ICT Strategy
Response by Medicines and Healthcare products Regulatory Agency to C E Mora on .

Awaiting classification.

FOI 20/263     Dear C E Mora,   Thank you for your email of 26 June 2020, requesting under the Freedom of Information (FOI) Act information...
MMR
Response by Medicines and Healthcare products Regulatory Agency to Robert Breslin on .

Successful.

Dear Mr Breslin Re: FOI 20/226 Thank you for your email. Please find the response to your request attached. Kind regards Pharmacovigilance Servic...
Co-proxamol Inconsistent Pricing
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Partially successful.

Dear Mr Kelly, Thank you for your email. Please find attached the response to your Internal Review. Kind Regards MHRA Customer Service Centre Medi...
Codes for identifying COVID shielded patient list within CPRD
Response by Medicines and Healthcare products Regulatory Agency to A Gibney on .

Information not held.

FOI 20/240 Dear A. Gibney, Thank you for your information request, dated 9th June 2020, where you asked: “Dear Medicines and Healthcare products Reg...
GCP inspection statements documenting serious breaches in 2018
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Partially successful.

22^nd may 2020   Dear Requestor,   REF: FOI 20/189   As requested under the Freedom of Information Act, please see below the response to y...
Safe Levels of adjuvant within vaccines
Response by Medicines and Healthcare products Regulatory Agency to gavin roberts on .

Successful.

Dear Mr Roberts, Many thanks for your information request dated 5th May where you asked how much adjuvant is currently within the Anthrax vaccine an...
MMR vaccine 2015-2020
Response by Medicines and Healthcare products Regulatory Agency to Marta Jazdzewska on .

Awaiting classification.

Dear Marta Jazdzewska Thank you for your recent Freedom of Information request. Please find a response attached. Kind regards, Chris Penny Pharmaco...
A list of all pharmaceutical manufacturers and suppliers registered with the Medicines & Healthcare products Regulatory Agency
Response by Medicines and Healthcare products Regulatory Agency to Nicola France on .

Successful.

Our Reference: CSC 4897 Dear Nicola France, Thank you for your email. Please review the following link of our website pages for the lists of manuf...
MMR
Response by Medicines and Healthcare products Regulatory Agency to Robert Breslin on .

Awaiting classification.

Thank you for your email.  This auto-response is to inform you that your email has been received and will be reviewed by our Customer Service Team sh...

Only requests made using WhatDoTheyKnow are shown. ?